Asston Pharmaceuticals Limited (BOM:544445)
62.45
-1.79 (-2.79%)
At close: Jul 27, 2026
Asston Pharmaceuticals Market Cap
Asston Pharmaceuticals has a market cap or net worth of 531.63 million as of July 28, 2026. Its market cap has decreased by -48.49% in one year.
Market Cap
531.63M
Enterprise Value
569.80M
Revenue
254.69M
Ranking
n/a
PE Ratio
12.69
Stock Price
62.45
ChartMarket Cap Chart
Since July 16, 2025, Asston Pharmaceuticals's market cap has decreased from 1.06B to 531.63M, a decrease of -50.02%. That is a compound annual growth rate of -49.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 531.63M | -24.33% |
| Dec 31, 2025 | 702.57M | -33.95% |
| Jul 16, 2025 | 1.06B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Source Natural Foods and Herbal Supplements | 706.45M |
| Onyx Biotec | 671.80M |
| Phaarmasia | 610.33M |
| Biofil Chemicals and Pharmaceuticals | 520.44M |
| ANG Lifesciences India | 469.31M |
| Shelter Pharma | 452.91M |
| Vista Pharmaceuticals | 447.48M |
| Mangalam Drugs & Organics | 427.84M |